The pathophysiology and current treatments for the subcutaneous panniculitis-like T cell lymphoma: An updated review

En Cheng Lin, Jia Bin Liao, Yu Han Fang, Chien Hui Hong*

*此作品的通信作者

研究成果: Review article同行評審

摘要

Subcutaneous panniculitis-like T cell lymphoma (SPTCL) is a rare cutaneous T cell lymphoma, which is indolent in nature but could claim life if not correctly diagnosed and promptly treated. SPTCL is usually presented clinically as painless subcutaneous and erythematous nodules over the trunk or extremities. Active clinical vigilance for these subcutaneous nodules or panniculitis-like lesions is warranted. A biopsy must be performed in order to make a correct diagnosis. Positron emission tomography scan is utilized for disease staging and treatment follow-up. Due to the rarity of this lymphoma, a standard treatment protocol is not established yet. However, most cases of SPTCL could be treated well under immunosuppressive or polychemotherapeutic drugs except in cases with hemophagocytic syndrome. Hematopoietic stem cell transplantation may be used in refractory or relapse cases. In this review, we presented a case of SPTCL with long-term complete remission. Meanwhile, since most clinical evidences and experiences of SPTCL are based mostly on case reports or small case series, and the understanding of the SPTCL pathophysiology is limited, we reviewed and updated the pathophysiology and treatments of SPTCL.

原文English
期刊Asia-Pacific Journal of Clinical Oncology
DOIs
出版狀態Accepted/In press - 2022

指紋

深入研究「The pathophysiology and current treatments for the subcutaneous panniculitis-like T cell lymphoma: An updated review」主題。共同形成了獨特的指紋。

引用此